Skip to main content
. Author manuscript; available in PMC: 2013 Oct 19.
Published in final edited form as: Recent Results Cancer Res. 2013;194:149–175. doi: 10.1007/978-3-642-27994-2_9

Figure 4.

Figure 4

PET/CT image of the biodistribution of the biodistribution of [68Ga]DOTA-GG-MTII; 35 MBq radiolabeled peptide; tail vein injection; 90 minute accumulation period; 15 minute static acquisition: (A) xenograft B16-F10 mouse melanoma tumor; (B) kidney accumulation and retention; (C) bladder accumulation and retention. The average and standard deviation of the biodistribution of [68Ga]DOTA-GG-MTII is given in Table 2.